AEye

AEYE Health is a digital health and healthcare AI company focused on autonomous diagnostic screening from retinal images. Its flagship commercial product, AEYE-DS, is an FDA-cleared point-of-care system that detects diabetic retinopathy from handheld or tabletop fundus cameras and returns an on-the-spot diagnostic result without physician interpretation. The company is also developing AEYE-X, an investigational broader retinal screening platform intended to diagnose or predict multiple ocular and systemic diseases from a single image per eye. AEYE Health operates at the intersection of ophthalmology, primary care, medical imaging, and artificial intelligence, positioning its products for use in clinics, home care, and other decentralized care settings.